Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Common Stock history
Currency unavailable · from the balance sheet
No Common Stock data reported for this period type.
Common Stock vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $48K USD | +2.1% | +1.4% | 0.0% | |
| Mar 2026 | $41K USD | +2.5% | +3.5% | 0.0% | |
| Mar 2026 | $1K USD | +0.0% | -58.5% | 0.0% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | +2.1% | +1.4% | 0.0% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.